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The definition of translational medicine integrates 
research from clinical and basic, social and political 
sciences, where the most important process is the 
conversion of biological discoveries into medical 
advantages.  
According to Marincola, translational medicine "is a 
two-way street where the drive to cure should be 
complemented by the pursuit to understand human 
diseases and their complexities" [1]. 
Transplantation from non-heart-beating donors 
(NHBD) is probably the most unusual example of 
translational medicine application, where the concept 
"Bench to Bedside and Bedside to Bench" has been 
liberally (and involuntarily) explicated.  
Historically, transplantations began in 1668 when a 
physician called Rob van Meekeren used a fragment from 
a dog's skull to cure a soldier's lesion. It was the first of an 
interminable list of attempts. For the first successful 
transplants, we need to wait until 1963, when Thomas 
Starzl performed a series of liver transplants, but no 
patient survived more than one month. In the same year 
James Hardy achieved the first lung transplant. The first 
successful heart human transplant was, instead, performed 
in 1967 by Christian Barnard in South Africa. In all these 
transplants the donor was a NHBD, a cadaver whose death 
was declared after the interruption of cardiac activity [2]. 
Only after the definition of brain death by the "Ad Hoc 
Committee of the Harvard Medical School to Examine the 
Definition of Brain Death" in 1968, the history of 
transplantation began to be inextricably linked to the 
evolution of heart-beating donors (HBD) or brain death 
donors [2]. Thanks to the availability of HBDs, NHBDs 
were abandoned as source of organs for many years. 
Nowadays, donation after cardiac death is again a concept 
widely spreading among people to increase the amount of 
transplantable organs even if there is reluctance to accept 
NHBD transplantation, because of the fear of poorer 
quality of organs compared to HBD [3]. For years, in 
clinical practice, surgeons are retrieving again organs 
from patients whose death was declared after cardiac 
arrest and this has pushed forward the research in the 
field. At the moment, experimental studies using animals 
or cells and clinical investigations are performed at the 
same time, but first observations about NHBD 
transplantation derived from clinical studies and not from 
experiments on animals, as it could be expected. It was the 
clinical practise and the patients' safety problems that 
brought forward the experimental observation on cells and 
animals: in this field the research went from the bedsides 
(of the deceased patients, unfortunately) to the 
experimental surgery benches. NHBD research focuses on 
grafts tolerance of ischemia, comparison of damage 
suffered after cardiac death and damage after brain death, 
and around improving grafts quality. The graft quality is 
strictly connected to the length of time of Warm Ischemia 
(WIT) and of Cold Ischemia (CIT). Every loss of time, 
every delay in the management of the donor and the graft 
is paid with a worse outcome of the organ and of the 
recipient. Organ transplants allow an effective treatment 
of patients with an end-stage organ failure that lead to an 
improvement in life quality and expectance. The necessity 
of an increased amount of transplantable organs makes the 
search of new organ sources essential. The knowledge of 
these sources of grafts is essential for the medical and 
paramedical staff, involved in death declaration and in the 
whole transplant proceedings since NHBD is not only a 
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